| (-)-epigallocatechin 3-gallate | multiple interactions | ISO | RGD:732520 | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of ARNTL mRNA | CTD | PMID:22079256 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:62295 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of ARNTL mRNA | CTD | PMID:18487412 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:62295 | 6480464 | Tetrachlorodibenzodioxin affects the expression of ARNTL mRNA | CTD | PMID:21182907 PMID:21570461 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of ARNTL mRNA | CTD | PMID:21215274 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:62295 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of ARNTL mRNA | CTD | PMID:18295293 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:62295 | 6480464 | Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to ARNTL protein] | CTD | PMID:21182907 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:62295 | 6480464 | Tetrachlorodibenzodioxin affects the expression of ARNTL mRNA; more ... | CTD | PMID:21182907 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:62295 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of ARNTL mRNA | CTD | PMID:18295293 PMID:19933214 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:62295 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of ARNTL mRNA | CTD | PMID:19933214 PMID:18295293 |
| all-trans-retinoic acid | multiple interactions | ISO | RGD:62295 | 6480464 | RARA protein inhibits the reaction [Tretinoin results in increased activity of [CLOCK protein binds to ARNTL protein]] | CTD | PMID:17069763 |
| all-trans-retinoic acid | increases expression | ISO | RGD:62295 | 6480464 | Tretinoin results in increased expression of ARNTL mRNA | CTD | PMID:9704006 |
| ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of ARNTL mRNA | CTD | PMID:16483693 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:62295 | 6480464 | [Benzo(a)pyrene co-treated with XPA gene mutant form co-treated with TRP53 gene mutant form] results in decreased expression of ARNTL mRNA | CTD | PMID:21715664 |
| benzo[a]pyrene | decreases expression | ISO | RGD:732520 | 6480464 | Benzo(a)pyrene results in decreased expression of ARNTL mRNA | CTD | PMID:21632981 PMID:22316170 |
| benzo[a]pyrene | increases expression | ISO | RGD:62295 | 6480464 | Benzo(a)pyrene results in increased expression of ARNTL mRNA | CTD | PMID:22228805 |
| benzo[a]pyrene | decreases expression | ISO | RGD:732520 | 6480464 | Benzo(a)pyrene results in decreased expression of ARNTL mRNA | CTD | PMID:22316170 |
| benzo[a]pyrene | decreases expression | ISO | RGD:62295 | 6480464 | Benzo(a)pyrene results in decreased expression of ARNTL mRNA | CTD | PMID:19770486 |
| bezafibrate | multiple interactions | ISO | RGD:62295 | 6480464 | [CLOCK protein binds to ARNTL protein] promotes the reaction [Bezafibrate results in increased expression of SERPINE1 mRNA] | CTD | PMID:20400680 |
| bis(2-ethylhexyl) phthalate | decreases expression | ISO | RGD:62295 | 6480464 | Diethylhexyl Phthalate results in decreased expression of ARNTL mRNA | CTD | PMID:19245819 |
| C60 fullerene | decreases expression | EXP | | 6480464 | fullerene C60 results in decreased expression of ARNTL mRNA | CTD | PMID:19167457 |
| cadmium dichloride | affects expression | EXP | | 6480464 | Cadmium Chloride affects the expression of ARNTL mRNA | CTD | PMID:21442002 |
| cadmium dichloride | decreases expression | EXP | | 6480464 | Cadmium Chloride results in decreased expression of ARNTL mRNA | CTD | PMID:20107868 |
| carmustine | decreases expression | EXP | | 6480464 | Carmustine results in decreased expression of ARNTL mRNA | CTD | PMID:16005536 |
| chloroprene | decreases expression | EXP | | 6480464 | Chloroprene results in decreased expression of ARNTL mRNA | CTD | PMID:23125180 |
| clofibrate | decreases expression | ISO | RGD:62295 | 6480464 | Clofibrate results in decreased expression of ARNTL mRNA | CTD | PMID:17585979 |
| cocaine | decreases expression | ISO | RGD:62295 | 6480464 | Cocaine results in decreased expression of ARNTL mRNA | CTD | PMID:15994025 |
| copper atom | multiple interactions | ISO | RGD:732520 | 6480464 | [NSC 689534 binds to Copper] which results in increased expression of ARNTL mRNA | CTD | PMID:20971185 |
| copper(0) | multiple interactions | ISO | RGD:732520 | 6480464 | [NSC 689534 binds to Copper] which results in increased expression of ARNTL mRNA | CTD | PMID:20971185 |
| copper(2+) sulfate | decreases expression | ISO | RGD:732520 | 6480464 | Copper Sulfate results in decreased expression of ARNTL mRNA | CTD | PMID:19549813 |
| cortisol | decreases expression | ISO | RGD:732520 | 6480464 | Hydrocortisone results in decreased expression of ARNTL mRNA | CTD | PMID:21980503 |
| dexamethasone | affects expression | ISO | RGD:732520 | 6480464 | Dexamethasone affects the expression of ARNTL mRNA | CTD | PMID:23251369 |
| diazoxide | increases expression | ISO | RGD:62295 | 6480464 | Isoproterenol results in increased expression of ARNTL mRNA | CTD | PMID:20003209 |
| fluoxetine | increases expression | ISO | RGD:62295 | 6480464 | Fluoxetine results in increased expression of ARNTL mRNA | CTD | PMID:15994025 |
| gold atom | multiple interactions | ISO | RGD:62295 | 6480464 | [Gold co-treated with Polyethylene Glycols] results in decreased expression of ARNTL mRNA | CTD | PMID:19695318 |
| gold(0) | multiple interactions | ISO | RGD:62295 | 6480464 | [Gold co-treated with Polyethylene Glycols] results in decreased expression of ARNTL mRNA | CTD | PMID:19695318 |
| indole-3-methanol | multiple interactions | EXP | | 6480464 | [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of ARNTL mRNA | CTD | PMID:22129741 |
| isoprenaline | increases expression | ISO | RGD:62295 | 6480464 | Isoproterenol results in increased expression of ARNTL mRNA | CTD | PMID:20003209 |
| methotrexate | affects expression | ISO | RGD:62295 | 6480464 | Methotrexate affects the expression of ARNTL mRNA | CTD | PMID:18502557 |
| methotrexate | decreases expression | EXP | | 6480464 | Methotrexate results in decreased expression of ARNTL mRNA | CTD | PMID:16005536 |
| N-acetyl-L-cysteine | multiple interactions | EXP | | 6480464 | [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of ARNTL mRNA | CTD | PMID:22129741 |
| N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of ARNTL mRNA | CTD | PMID:18164116 |
| N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of ARNTL mRNA | CTD | PMID:22129741 |
| paracetamol | affects expression | ISO | RGD:62295 | 6480464 | Acetaminophen affects the expression of ARNTL mRNA | CTD | PMID:17562736 |
| perfluorooctane-1-sulfonic acid | decreases expression | EXP | | 6480464 | perfluorooctane sulfonic acid results in decreased expression of ARNTL mRNA | CTD | PMID:19162173 |
| perfluorooctanoic acid | decreases expression | EXP | | 6480464 | perfluorooctanoic acid results in decreased expression of ARNTL mRNA | CTD | PMID:19162173 |
| phenobarbital | decreases expression | ISO | RGD:62295 | 6480464 | Phenobarbital results in decreased expression of ARNTL mRNA | CTD | PMID:19270015 |
| phenobarbital | affects expression | ISO | RGD:62295 | 6480464 | Phenobarbital affects the expression of ARNTL mRNA | CTD | PMID:23091169 |
| phenobarbital | increases expression | ISO | RGD:62295 | 6480464 | Phenobarbital results in increased expression of ARNTL mRNA | CTD | PMID:19270015 |
| pirinixic acid | decreases expression | ISO | RGD:62295 | 6480464 | pirinixic acid results in decreased expression of ARNTL mRNA | CTD | PMID:17426115 |
| pirinixic acid | increases expression | ISO | RGD:62295 | 6480464 | pirinixic acid results in increased expression of ARNTL mRNA | CTD | PMID:18445702 |
| prednisolone | increases expression | ISO | RGD:732520 | 6480464 | Prednisolone results in increased expression of ARNTL mRNA | CTD | PMID:16269518 |
| prednisolone | increases expression | ISO | RGD:62295 | 6480464 | Prednisolone results in increased expression of ARNTL mRNA | CTD | PMID:16269518 |
| quercetin | increases expression | ISO | RGD:732520 | 6480464 | Quercetin results in increased expression of ARNTL mRNA | CTD | PMID:21632981 |
| Se-methyl-L-selenocysteine | decreases expression | EXP | | 6480464 | selenomethylselenocysteine results in decreased expression of ARNTL mRNA | CTD | PMID:19122877 |
| Se-methylselenocysteine | decreases expression | EXP | | 6480464 | selenomethylselenocysteine results in decreased expression of ARNTL mRNA | CTD | PMID:19122877 |
| sevoflurane | affects expression | EXP | | 6480464 | sevoflurane affects the expression of ARNTL mRNA | CTD | PMID:15967596 |
| tioguanine | decreases expression | EXP | | 6480464 | Thioguanine results in decreased expression of ARNTL mRNA | CTD | PMID:16005536 |
| valproic acid | affects expression | ISO | RGD:62295 | 6480464 | Valproic Acid affects the expression of ARNTL mRNA | CTD | PMID:17963808 |
| zinc atom | multiple interactions | ISO | RGD:732520 | 6480464 | [PCI 5002 co-treated with Zinc] results in increased expression of ARNTL mRNA | CTD | PMID:18593933 |
| zinc(0) | multiple interactions | ISO | RGD:732520 | 6480464 | [PCI 5002 co-treated with Zinc] results in increased expression of ARNTL mRNA | CTD | PMID:18593933 |
| zoledronic acid | increases expression | ISO | RGD:732520 | 6480464 | zoledronic acid results in increased expression of ARNTL mRNA | CTD | PMID:20977926 |